Increasing incidence of cancer and growing demand for cancer pain drugs to alleviate pain are some key factors driving growth of the cancer pain market
Market Size – USD 6,080.5 Million in 2020, Market Growth – at a CAGR of 4.3%, Market Trends – Growing geriatric population
The global cancer pain market size is expected to reach USD 8,548.1 Million by 2028 and register a CAGR of 4.3% during the forecast period, according to a latest report by Reports and Data. Steady cancer pain market revenue growth can be attributed to increasing prevalence of cancer. It has been estimated that in 2020, about 1.8 million new cancer cases were diagnosed in the US and about 0.6 million deaths were due to the disease. Also, by 2030, the number of survivors of cancer in the US is projected to rise to more than 22.0 million. Cancer pain drugs find use in effective management of pain in cancer patients. Even though complete relief from pain in not always possible in patient experiencing pain, it can be reduced in almost all cases through proper medication. Effective pain management aids in enhancing quality of life of cancer patients.
Growing geriatric population and high incidence of multiple comorbidities are creating rising demand for more innovative drugs to manage pain. In addition, increase investments in research and development activities among major companies is another factor propelling market growth. The possibility of occurrence of cancer in persons in the age group of 65 years and above is significantly higher than it is in younger individuals. Also, about 60.0% of cases of cancer diagnosis is among the geriatric population. The effect and intensity of pain as individuals get older is high, and more effective pain management is required, which is a factor driving market revenue growth.
Get a sample of the report @https://www.reportsanddata.com/sample-enquiry-form/4126
The report provides a panoramic view of the market and insights that will help formulate better business decisions. In addition to that, the study helps well-established companies and players gain a deeper understanding of the market and make informed decisions. The report also discusses in detail about the key factors influencing the market growth.
Key companies operating in the market include:
Sanofi SA, Teva Pharmaceuticals Industries Ltd., Johnson & Johnson, Daiichi Sankyo Company, BioDelivery Sciences International, Sorrento Therapeutics Inc., Pfizer Inc., Hisamitsu Pharmaceutical Co. Ltd., Orexo AB, and Insys Therapeutics Inc.
The report covers an extensive analysis of the key market players in the market along with their business overview, expansion plans, and strategies. The report also focuses on recent strategic alliances in the market including mergers and acquisitions, joint ventures, partnerships, agreements, corporate and government deals, product launches, and brand promotions, among others.
Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/4126
The report aims to provide a better understanding of the market dynamics and the workings of the industry on a global level. To gain a deeper understanding of the industry, the global Cancer Pain market is further segmented on the basis of key geographical regions such as North America, Latin America, Europe, Asia-Pacific, and the Middle East & Africa. The report also offers a country-wise analysis to provide crucial insights into market size, market growth, market revenue growth, and economic growth in each region.
On basis of product types and application offered by the Cancer Pain industry, the market is segmented into:
Drug Type Outlook (Revenue, USD Million; 2018-2028)
• Opioids
• Non-steroidal Anti-inflammatory Drugs
• Others
Route of Administration Outlook (Revenue, USD Million; 2018-2028)
• Parenteral
• Oral
• Others
Application Outlook (Revenue, USD Million; 2018-2028)
• Lung Cancer
• Colorectal Cancer
• Breast Cancer
• Blood Cancer
• Prostate Cancer
• Others
End-Use Outlook (Revenue, USD Million; 2018-2028)
• Hospitals
• Specialty Clinics
• Homecare
• Others


The regional analysis covers:
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o U.K.
o Italy
o France
o BENELUX
o Rest of Europe
• Asia Pacific
o China
o India
o Japan
o South Korea
o Rest of APAC
• Latin America
o Brazil
o Rest of LATAM
• Middle East & Africa
o Saudi Arabia
o U.A.E.
o South Africa
o Rest of MEA
To know more about the report @ https://www.reportsanddata.com/report-detail/cancer-pain-market

Increasing incidence of cancer and growing demand for cancer pain drugs to alleviate pain are some key factors driving growth of the cancer pain market Market Size – USD 6,080.5 Million in 2020, Market Growth – at a CAGR of 4.3%, Market Trends – Growing geriatric population The global cancer pain market size is expected to reach USD 8,548.1 Million by 2028 and register a CAGR of 4.3% during the forecast period, according to a latest report by Reports and Data. Steady cancer pain market revenue growth can be attributed to increasing prevalence of cancer. It has been estimated that in 2020, about 1.8 million new cancer cases were diagnosed in the US and about 0.6 million deaths were due to the disease. Also, by 2030, the number of survivors of cancer in the US is projected to rise to more than 22.0 million. Cancer pain drugs find use in effective management of pain in cancer patients. Even though complete relief from pain in not always possible in patient experiencing pain, it can be reduced in almost all cases through proper medication. Effective pain management aids in enhancing quality of life of cancer patients. Growing geriatric population and high incidence of multiple comorbidities are creating rising demand for more innovative drugs to manage pain. In addition, increase investments in research and development activities among major companies is another factor propelling market growth. The possibility of occurrence of cancer in persons in the age group of 65 years and above is significantly higher than it is in younger individuals. Also, about 60.0% of cases of cancer diagnosis is among the geriatric population. The effect and intensity of pain as individuals get older is high, and more effective pain management is required, which is a factor driving market revenue growth. Get a sample of the report @https://www.reportsanddata.com/sample-enquiry-form/4126 The report provides a panoramic view of the market and insights that will help formulate better business decisions. In addition to that, the study helps well-established companies and players gain a deeper understanding of the market and make informed decisions. The report also discusses in detail about the key factors influencing the market growth. Key companies operating in the market include: Sanofi SA, Teva Pharmaceuticals Industries Ltd., Johnson & Johnson, Daiichi Sankyo Company, BioDelivery Sciences International, Sorrento Therapeutics Inc., Pfizer Inc., Hisamitsu Pharmaceutical Co. Ltd., Orexo AB, and Insys Therapeutics Inc. The report covers an extensive analysis of the key market players in the market along with their business overview, expansion plans, and strategies. The report also focuses on recent strategic alliances in the market including mergers and acquisitions, joint ventures, partnerships, agreements, corporate and government deals, product launches, and brand promotions, among others. Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/4126 The report aims to provide a better understanding of the market dynamics and the workings of the industry on a global level. To gain a deeper understanding of the industry, the global Cancer Pain market is further segmented on the basis of key geographical regions such as North America, Latin America, Europe, Asia-Pacific, and the Middle East & Africa. The report also offers a country-wise analysis to provide crucial insights into market size, market growth, market revenue growth, and economic growth in each region. On basis of product types and application offered by the Cancer Pain industry, the market is segmented into: Drug Type Outlook (Revenue, USD Million; 2018-2028) • Opioids • Non-steroidal Anti-inflammatory Drugs • Others Route of Administration Outlook (Revenue, USD Million; 2018-2028) • Parenteral • Oral • Others Application Outlook (Revenue, USD Million; 2018-2028) • Lung Cancer • Colorectal Cancer • Breast Cancer • Blood Cancer • Prostate Cancer • Others End-Use Outlook (Revenue, USD Million; 2018-2028) • Hospitals • Specialty Clinics • Homecare • Others The regional analysis covers: • North America o U.S. o Canada o Mexico • Europe o Germany o U.K. o Italy o France o BENELUX o Rest of Europe • Asia Pacific o China o India o Japan o South Korea o Rest of APAC • Latin America o Brazil o Rest of LATAM • Middle East & Africa o Saudi Arabia o U.A.E. o South Africa o Rest of MEA To know more about the report @ https://www.reportsanddata.com/report-detail/cancer-pain-market
WWW.REPORTSANDDATA.COM
Cancer Pain Market Size, Growth & Demand | Industry Analysis
The global cancer pain market size was USD 6,080.5 Million in 2020 and is expected to reach USD 8,548.1 Million in 2028 and register a CAGR of 4.3% over the forecast period. Increasing healthcare expenditure in developing countries for cancer treatment in also driving market growth
0 Comments 0 Shares